Brief: AnaptysBio Q3 Net Income USD -32.851 Million
05/11/2024 21:15
Nov 05 (Reuters) - AnaptysBio Q3 operating expenses USD 52.774 million. * Q3 income from operations USD -22.757 million * Q3 collaboration revenue USD 30.017 million
Recent news on AnaptysBio
See all newsU.S. RESEARCH ROUNDUP- Applied Materials, NVIDIA, Thermo Fisher Scientific
AnaptysBio's Q1 collaboration revenue falls, net loss widens
Brief: AnaptysBio Q1 Net Income USD -52.884 Million
Brief: Anaptys Appoints Chris Murphy As Chief Financial Officer And Owen Hughes To Board Of Directors
Brief: GSK Says Unit Tesaro's Claim For Declaratory Judgment Against Anaptysbio Unchanged